202 related articles for article (PubMed ID: 36933020)
21. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
Liao R; Li DW; Du CY; Li M
J Gastrointest Surg; 2018 Oct; 22(10):1679-1687. PubMed ID: 29777455
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
Kim AY; Sinn DH; Jeong WK; Kim YK; Kang TW; Ha SY; Park CK; Choi GS; Kim JM; Kwon CHD; Joh JW; Kim MJ; Sohn I; Jung SH; Paik SW; Lee WJ
J Hepatol; 2018 Jun; 68(6):1144-1152. PubMed ID: 29410377
[TBL] [Abstract][Full Text] [Related]
23. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
24. Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma?
Wei H; Jiang H; Liu X; Qin Y; Zheng T; Liu S; Zhang X; Song B
Eur J Radiol; 2020 Nov; 132():109312. PubMed ID: 33022551
[TBL] [Abstract][Full Text] [Related]
25. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
[TBL] [Abstract][Full Text] [Related]
26. Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
Jiang H; Qin Y; Wei H; Zheng T; Yang T; Wu Y; Ding C; Chernyak V; Ronot M; Fowler KJ; Chen W; Bashir MR; Song B
Eur Radiol; 2024 May; 34(5):3163-3182. PubMed ID: 37870624
[TBL] [Abstract][Full Text] [Related]
27. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement as a risk factor for late recurrence (>1 year) of hepatocellular carcinoma after surgery.
Matsuda M; Ichikawa S; Matsuda M; Amemiya H; Ichikawa D; Onishi H; Motosugi U
Clin Radiol; 2019 Dec; 74(12):975.e1-975.e9. PubMed ID: 31540704
[TBL] [Abstract][Full Text] [Related]
30. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
31. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
Ryu T; Takami Y; Wada Y; Tateishi M; Hara T; Yoshitomi M; Momosaki S; Yasumori K; Saitsu H; Okuda K
J Gastrointest Surg; 2019 Apr; 23(4):779-787. PubMed ID: 30788712
[TBL] [Abstract][Full Text] [Related]
32. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
33. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
[TBL] [Abstract][Full Text] [Related]
34. Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score.
Kim DW; Lee SS; Kim SO; Kim JH; Kim HJ; Byun JH; Yoo C; Kim KP; Song KB; Kim SC
Radiology; 2020 Sep; 296(3):541-551. PubMed ID: 32662759
[TBL] [Abstract][Full Text] [Related]
35. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
37. Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
Kim H; Park MS; Park YN; Kim H; Kim KS; Choi JS; Ahn SH; Han KH; Kim MJ; Kim KW
Yonsei Med J; 2009 Dec; 50(6):789-95. PubMed ID: 20046419
[TBL] [Abstract][Full Text] [Related]
38. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
39. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.
Kim TH; Woo S; Han S; Suh CH; Lee DH; Lee JM
Eur Radiol; 2020 Mar; 30(3):1624-1633. PubMed ID: 31776747
[TBL] [Abstract][Full Text] [Related]
40. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
